OptiNose, Inc. (NASDAQ:OPTN) Q3 2024 Earnings Call Transcript
Operator: Good day, and welcome to the OptiNose Third Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.
Optinose Inc. (OPTN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 14,356,703 | $9,618,991 | +7% | 0.48% |
| 2. | Great Point Partners Jeffrey Jay And David Kroin | 12,861,136 | $8,616,961 | -7% | 2.53% |
| 3. | Stonepine Capital Timothy P. Lynch | 5,688,590 | $3,811,355 | +143% | 2.4% |
| 4. | Kingdon Capital Mark Kingdon | 5,599,237 | $3,751,489 | 0.41% | |
| 5. | D E Shaw D. E. Shaw | 5,000,000 | $3,350,000 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.06 | 34,000 | Officer | 142,278 | 2021-05-20 | Filing | |
| $2.99 | 10,000 | Director | 31,230 | 2021-05-10 | Filing | |
| $3.91 | 11,742 | Officer, Director | 636,955 | 2021-03-18 | Filing | |
| $3.85 | 787 | Officer, Director | 625,213 | 2021-03-17 | Filing | |
| $3.90 | 2,500 | Officer | 9,751 | 2020-09-23 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.87 | 3,226 | Officer | 547,238 | 2024-09-17 | Filing | |
| $0.87 | 4,881 | Officer, Director | 1,202,097 | 2024-09-17 | Filing | |
| $1.14 | 6,845 | Officer | 140,758 | 2024-07-17 | Filing | |
| $1.14 | 49,408 | Officer | 550,464 | 2024-07-17 | Filing | |
| $1.14 | 111,426 | Officer, Director | 1,206,978 | 2024-07-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 14,666,941 | $18,920,354 | 0% | |
| 2. | 14,605,263 | $18,767,763 | 10.93% | |
| 3. | 4,885,580 | $6,302,398 | 5.19% | |
| 4. | 4,404,251 | $5,681,483 | 0% | |
| 5. | 4,179,704 | $5,391,818 | 0% |
News See All
OptiNose, Inc. (NASDAQ:OPTN) Q2 2024 Earnings Call Transcript
Operator: Hello, and welcome to the OptiNose Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
OptiNose, Inc. (NASDAQ:OPTN) Q1 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the OptiNose's Q1 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
OptiNose, Inc. (NASDAQ:OPTN) Q4 2023 Earnings Call Transcript
OptiNose, Inc. beats earnings expectations. Reported EPS is $-9.0E-5, expectations were $-0.1.
OptiNose, Inc. (NASDAQ:OPTN) Q3 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to OptiNose Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
OptiNose, Inc. (NASDAQ:OPTN) Q2 2023 Earnings Call Transcript
Operator: Hello. Good day everyone and thank you for standing by. Welcome to the OptiNose Second Quarter 2023 Earnings Call. At this time, all participants are in a listen only mode.
OptiNose, Inc. (NASDAQ:OPTN) Q1 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the OptiNose's First Quarter 2023 Earnings Conference Call.
OptiNose, Inc. (NASDAQ:OPTN) Q4 2022 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the OptiNose's Fourth Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode.
OptiNose, Inc. (NASDAQ:OPTN) Q3 2022 Earnings Call Transcript
Jonathan Neely: Third quarter 2022 performance and our plans for the remainder of the year. I'm joined today by our CEO, Peter Miller; our President and Chief Operating Officer, Dr.
10 Best Penny Stocks to Buy in July
Penny stocks are priced under $5 and often represent high-risk public companies that do offer exponential growth potential.